Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)

CNY 62.27

(-1.16%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.88 Billion 1.66 Billion 1.74 Billion 1.97 Billion 320.26 Million 454.88 Million
Total Current Assets 2.52 Billion 1.29 Billion 1.4 Billion 1.66 Billion 101.82 Million 229.67 Million
Cash And Short Term Investments 2.24 Billion 1.04 Billion 1.2 Billion 1.59 Billion 72.92 Million 128.93 Million
Cash and Cash Equivalents 2.1 Billion 797.04 Million 1.13 Billion 1.14 Billion 66.92 Million 128.93 Million
Short Term Investments 137.01 Million 248.93 Million 65.25 Million 449.84 Million 6 Million 82.6 Million
Net Receivables 116.57 Million 142.29 Million 126.85 Million 46.45 Million 7.02 Million 15.58 Million
Inventory 110.85 Million 98.97 Million 51.91 Million 23.13 Million 6.42 Million 2.55 Million
Other Current Assets 46.25 Million 4.5 Million 25.3 Million 391.49 Thousand 15.44 Million 82.6 Million
Total Non-Current Assets 366.87 Million 376.55 Million 340 Million 300.71 Million 218.44 Million 225.2 Million
Net PPE 275.22 Million 247.08 Million 188.91 Million 91.02 Million 56.66 Million 56.98 Million
Good Will And Intangible Assets 69.26 Million 91.02 Million 116.29 Million 129.51 Million 135.8 Million 156.42 Million
Good Will - - - - - -
Intangible Assets 69.26 Million 91.02 Million 116.29 Million 129.51 Million 135.8 Million 156.42 Million
Long-Term Investments 5.98 Million -238.93 Million -55.25 Million -439.84 Million - -
Tax Assets 1.00 238.93 Million 78.28 Million 454.2 Million - -
Other Non Current Assets 16.39 Million 38.43 Million 11.77 Million 65.82 Million 25.96 Million 11.79 Million
Other Assets 1.00 1.00 - - - -
Total Liabilities 1.23 Billion 880.82 Million 492.87 Million 278.69 Million 246.51 Million 173.24 Million
Total Current Liabilities 1.13 Billion 729.18 Million 380.89 Million 140.87 Million 150.16 Million 77.55 Million
Account Payables 137.73 Million 151.72 Million 118.19 Million 64.95 Million 54.03 Million 63.51 Million
Tax Payables 20.63 Million 29.01 Million 25.1 Million 24.65 Million 17.97 Million 943.59 Thousand
Short Term Debt 856.96 Million 454.52 Million 175.39 Million 17.66 Million 60 Million -45.19 Thousand
Deferred Revenue 107.03 Thousand 278.76 Thousand 87.26 Million - - 45.19 Thousand
Other Current Liabilities 140.37 Million 122.66 Million 46.67 Thousand 58.25 Million 36.13 Million 14.04 Million
Total Non Current Liabilities 95.64 Million 151.63 Million 111.98 Million 137.81 Million 96.34 Million 95.68 Million
Long-Term Debt 29.45 Million 93.27 Million 48.17 Million 30.03 Million 2.00 1.00
Deferred Revenue Non Current 11.54 Million 45.04 Million 48.04 Million 83.65 Million 66.22 Million 61.94 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 45.05 Million 1.00 1.00 4.31 Million 4.82 Million 4.52 Million
Other Liabilities 1.00 1.00 1.00 1.00 - 1.00
Total Equity 1.64 Billion 787.48 Million 1.25 Billion 1.69 Billion 73.75 Million 281.64 Million
Stock Holders Equity 1.63 Billion 759.11 Million 1.19 Billion 1.61 Billion 3.42 Million 226.3 Million
Common Stock 264.7 Million 240 Million 240 Million 240 Million 180 Million 40.42 Million
Retained Earnings -1.97 Billion -1.7 Billion -1.24 Billion -791.55 Million -472.32 Million -796.73 Million
Accumulated other comprehensive income 68.06 Million 118.33 Million 77.78 Million 48.18 Million 31.58 Million 982.62 Million
Common Stock Equity 1.63 Billion 759.11 Million 1.19 Billion 1.61 Billion 3.42 Million 226.3 Million
Capital Lease Obligation 29.45 Million 43.18 Million 48.17 Million 6.68 Million 4.82 Million 4.52 Million
Total Investments 143 Million 10 Million 10 Million 10 Million 6 Million 82.6 Million
Total Debt 886.42 Million 547.79 Million 223.56 Million 47.7 Million 60 Million 4.52 Million
Net Debt -1.22 Billion -249.24 Million -913.06 Million -1.1 Billion -6.92 Million -124.4 Million

Balance Sheet Charts